WeVote
Log In

Bill

Bill

S 4444

Requires health insurance coverage for certain neurological diseases.

2024-2025 Regular Session Introduced by Jim Beach and 5 co-sponsors

New Jersey bill mandates health insurance coverage for treatments of certain neurological diseases, potentially improving patient access but likely raising insurance costs.

Introduced in the Senate, Referred to Senate Commerce Committee
#disease #healthinsur
0
WeVote Research Nonpartisan
Bill Summary · S 4444

Legislative bill overview

S 4444 requires health insurance plans in New Jersey to cover treatments and therapies for specified neurological diseases. The bill was introduced in May 2025 and is currently under review by the Senate Commerce Committee. The specific neurological conditions covered and the scope of required treatments have not been detailed in the available legislative summary.

Why is this important

Neurological diseases like Parkinson's, ALS, multiple sclerosis, and epilepsy can require expensive ongoing treatments and therapies that insurance plans may not fully cover. Mandating coverage could reduce out-of-pocket costs for patients and families while potentially increasing treatment accessibility across the state. However, expanded insurance mandates typically raise premiums for all policyholders.

Potential points of contention

  • Cost and premium impact: Insurers may argue that coverage mandates increase overall healthcare costs, which could be passed to consumers through higher premiums or reduced benefits elsewhere
  • Definition specificity: The bill's effectiveness depends on clearly defining which neurological diseases qualify and what treatments must be covered, leaving room for implementation disputes
  • Insurance market effects: Stricter mandates may influence which insurers operate in New Jersey or how they structure plans, potentially limiting consumer choice or availability in certain regions

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.